Category Pfizer
Will Pfizer’s YaoPharma deal deliver a powerful new oral obesity pill?
Pfizer is rolling the dice again on an oral obesity pill. The pharmaceutical giant signed an exclusive global license agreement with YaoPharma, a s...
Dec, 09, 2025
2 min read
by Invezz
US digest: Nvidia rebounds ahead of rarnings, Apple delays new iPhone Air, Trump eyes debt paydown
US markets opened Monday with renewed optimism as investors reacted to progress toward ending the government shutdown and a series of major corpora...
Nov, 10, 2025
3 min read
by Invezz
Dow futures gain over 200 points on Monday: 5 things to know before Wall Street opens
Dow futures showed a positive trajectory Monday morning, climbing amid growing optimism over a potential end to the longest US government shutdown ...
Nov, 10, 2025
3 min read
by Invezz
Pfizer clinches $10 billion Metsera deal, outbidding Novo Nordisk
Pfizer acquires Metsera for $10 billion, cementing their new obesity treatment strategy. The purchase concludes a weeklong bidding frenzy between t...
Nov, 08, 2025
3 min read
by Invezz
Trump strikes deal with Eli Lilly, Novo Nordisk to cut GLP-1 weight-loss drug prices
President Donald Trump announced a landmark agreement Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to dramatically slash prices f...
Nov, 06, 2025
3 min read
by Invezz